leisure time -WSS

leisure time

author：leisure time 2025-10-01 22:48:26 - browse：7591

ANDREW YATES/AFP via Getty Images

In patients with stage 3 lung cancer where a particular genetic mutation is present in the tumor, taking AstraZeneca’s cancer-fighting pill Tagrisso reduced the chance that disease would progress by 84%.

“This will be practice changing as soon as this becomes available,” said David R. Spigel, chief scientific officer of the Sarah Cannon Research Institute at a press conference announcing the results at the annual meeting of the American Society of Clinical Oncology. “This will be how patients are treated wherever they can get access to this drug.”

Spigel but was not involved in the Tagrisso study but has relationships with multiple drugmakers including AstraZeneca.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Information blocking fines are now fair game in health care

WSS

FDA panel to weigh safety of artificial wombs for preterm births

Medicare Advantage coverage denials need scrutiny, senators say

Why the drug industry's warnings on the IRA's impact fall short

Chamber of Commerce, DOJ clash in court over drug prices

American taxpayers paid $1.8 trillion in health care costs in 2022

Assistant physicians can help address the primary care shortage

entertainment

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

explore

Medicare details structure of new drug price negotiation program

Bankrupt Pear's prescription app helped MassHealth save money, data suggests

Walensky prepares to leave CDC — and Congress — behind

Information blocking fines are now fair game in health care

Walensky prepares to leave CDC — and Congress — behind

Physician assistants need a new name. Here's what it should be

Dobbs anniversary: the lost opportunity of abortion as health care

Profiling embryos to choose those with higher IQs is almost a reality

United colonoscopy coverage change 'may cost lives,' doctors say

Hospital chaplains balance Covid safety with patients’ spiritual needs

focus

Merck to acquire Harpoon Therapeutics for $680 million

Why the drug industry's warnings on the IRA's impact fall short

Male doctors called my cancer incurable. A female doctor showed it wasn't

How the messy conversation about Dolly changed bioethics

Patients, doctors press FTC to beef up hospital merger scrutiny

Life science postdocs should get big pay hike, NIH panel says

explore

explore

entertainment

Wikipedia